Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11633494 Compounds and compositions for immunotherapy

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Lixin Li0

Date of Patent

April 25, 2023

0

Patent Application Number

169348030

Date Filed

July 21, 2020

0

Patent Citations

US Patent 11046781 Anti-HER2 combinations for treating tumors

0

US Patent 11053240 2-amino-quinoline derivatives

0

US Patent 11220552 Anti-CD20 combinations for treating tumors

0

US Patent 11279761 Anti-PD-L1 combinations for treating tumors

0

US Patent 10548988 Compounds for targeted immunotherapy

0

US Patent 10660971 Compounds for targeted immunotherapy

0

US Patent 10744206 Compounds and compositions for immunotherapy

0

US Patent 10780180 Compounds and compositions for immunotherapy

0

...

Patent Primary Examiner

0

CPC Code

0

0

0

0

0

0

0

0

...

The present invention relates to compounds for targeted immunotherapy, as well as compositions comprising the same. Further, the present invention relates to the use of the compounds in the treatment of diseases such as cancer.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11633494 Compounds and compositions for immunotherapy

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool